Search - tctmd.com

Displaying 401 - 420 of 1818

Sort: Relevancy | Date

Presentation TCT 2024

TricValve

Presenter: Ignacio Amat-Santos

October 29, 2024

Presentation TCT 2024

The Trillium Heterotopic Cross-Caval TTVR System

Presenter: Ran Kornowski

October 29, 2024

Presentation TCT 2024

The Edwards Caval Pre-stent TTVR System

Presenter: Brian O'Neill

October 29, 2024

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

Case 1: TTVI in Lead Induced TR: Assessment and Management

Presenter: Julia Grapsa

October 29, 2024

Presentation TCT 2024

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

Presenter: Isaac George

October 29, 2024

Presentation TCT 2024

The Topaz TTVR System: Technology for Expanded Access and EFS Update

Presenter: Hendrik Treede

October 29, 2024

Presentation TCT 2024

The MonarQ TTVR First-in-Human Experience

Presenter: Arshad Quadri

October 29, 2024

Presentation TCT 2024

The Laplace TTVR System

Presenter: Pradeep Yadav

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

Presenter: Juan Granada

October 29, 2024

Presentation TCT 2024

The Intrepid TTVR Clinical Program

Presenter: Firas Zahr

October 29, 2024

Presentation TCT 2024

The Cardiovalve TTVR Clinical Program

Presenter: Christian Frerker

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Presenter: Ricky E Lemus-Zamora

October 29, 2024

Presentation TCT 2024

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

October 29, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 1543: Combined Apical Left Ventricular Thrombus Removal With Concomitant Ventricular Tachycardia Ablation

Presenter: Rashid Alhusain

October 29, 2024

Advertisement

TricValve

The Trillium Heterotopic Cross-Caval TTVR System

The Edwards Caval Pre-stent TTVR System

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Case 1: TTVI in Lead Induced TR: Assessment and Management

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

The Topaz TTVR System: Technology for Expanded Access and EFS Update

The MonarQ TTVR First-in-Human Experience

The Laplace TTVR System

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

The Intrepid TTVR Clinical Program

The Cardiovalve TTVR Clinical Program

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 1543: Combined Apical Left Ventricular Thrombus Removal With Concomitant Ventricular Tachycardia Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content